FrancophonIA/ELRC3.0 huggingface dataset:
English: • if you are allergic to follicle stimulating hormone (FSH), luteinising hormone (LH) or any of the other ingredients of this medicine (listed in section 6)
Slovenian: • če ste alergični na folikle stimulirajoči hormon (FSH), luteinizirajoči hormon (LH) ali katero koli sestavino tega zdravila (navedeno v poglavju 6),
English: 6.6 Special precautions for disposal and other handling Only clear solution without particles should be used.
Slovenian: 6.6 Posebni varnostni ukrepi za odstranjevanje in ravnanje z zdravilom Uporabljajte samo bistro raztopino brez delcev.
English: When you get the desired response, you will be given a single injection of human chorionic gonadotropin (hCG) 24 to 48 hours after your last Pergoveris injection.
Slovenian: Ko dosežete želeni odziv, boste dobili eno samo injekcijo humanega horionskega gonadotropina (hCG) 24 do 48 ur po zadnji injekciji zdravila Pergoveris.
English: Pergoveris is indicated for use in infertility (see section 4.1).
Slovenian: Zdravilo Pergoveris je indicirano za uporabo pri neplodnosti (glejte poglavje 4.1).
English: Usually, OHSS resolves spontaneously with the onset of menses.
Slovenian: OHSS običajno spontano izzveni ob nastopu menstruacije.
English: Monitoring of stimulation cycles by ultrasound scans as well as oestradiol measurements are recommended to early identify risk factors.
Slovenian: Priporočeno je nadzorovanje ciklov stimulacije z ultrazvokom ter meritve estradiola za zgodnje odkrivanje dejavnikov tveganja.
English: In this case, your doctor will give you a lower follitropin alfa dose in the following cycle.
Slovenian: V tem primeru vam bo zdravnik v naslednjem ciklu dal manjši odmerek folitropina alfa.
English: • you have stomach, arm or leg pain.
Slovenian: • imate bolečine v trebuhu, rokah ali nogah.
English: • Serious blood clotting problems (thromboembolic events) usually with severe OHSS are found very rarely.
Slovenian: • Resni zapleti zaradi krvnih strdkov (trombembolični dogodki), običajno pri hudi OHSS, so zelo redki.
English: • The pen comes in 3 different multi-dose presentations:
Slovenian: • Peresnik je na voljo v 3 različnih večodmernih oblikah:
English: • Record the treatment day number (column 1), date (column 2), time of your injection (column
Slovenian: • Zabeležite številko dneva zdravljenja (stolpec 1), datum (stolpec 2), čas injiciranja
English: • It comes as a powder and liquid, which you need to mix together and then use straight away.
Slovenian: • Zdravilo je v obliki praška in tekočine, ki ju zmešate in takoj uporabite.
English: Safety, efficacy, and pharmacokinetics of this medicinal product in patients with renal or hepatic impairment have not been established.
Slovenian: Varnost, učinkovitost in farmakokinetika tega zdravila pri bolnikih z okvaro ledvic ali jeter niso bile dokazane.
English: • if you have unexplained vaginal bleeding
Slovenian: • če imate nepojasnjeno krvavitev iz nožnice,
English: Wipe the skin with an alcohol swab.
Slovenian: Kožo obrišite z alkoholno blazinico.
English: Warning: If the Dose Feedback Window shows a number higher than 0, the Pergoveris pre-filled pen is empty and you have not received your full prescribed dose.
Slovenian: Opozorilo: Če je številka v okencu za prikaz odmerka večja od 0, to pomeni, da je Pergoveris napolnjen injekcijski peresnik prazen in da niste prejeli celotnega predpisanega odmerka.
English: • hypersensitivity to the active substances or to any of the excipients listed in section 6.1
Slovenian: • s preobčutljivostjo na učinkovini ali katero koli pomožno snov, navedeno v poglavju 6.1;
English: To minimise the risk of multiple pregnancy, careful monitoring of ovarian response is recommended.
Slovenian: Za zmanjšanje tveganja večplodne nosečnosti, se priporoča skrbno spremljanje ovarijskega odziva.
English: Following subcutaneous administration, the absolute bioavailability is approximately 60%; the terminal half-life is slightly prolonged.
Slovenian: Po subkutani aplikaciji je absolutna biološka uporabnost okoli 60 %; končni razpolovni čas je rahlo podaljšan.
English: Driving and using machines It is not expected that this medicine will affect your ability to drive or use machines.
Slovenian: Vpliv na sposobnost upravljanja vozil in strojev Ne pričakuje se, da bi zdravilo vplivalo na sposobnost vožnje ali upravljanja strojev.
English: A. MANUFACTURERS OF THE BIOLOGICAL ACTIVE SUBSTANCES AND MANUFACTURER RESPONSIBLE FOR BATCH RELEASE
Slovenian: A. IZDELOVALCI BIOLOŠKE UČINKOVINE IN IZDELOVALEC, ODGOVOREN ZA SPROŠČANJE SERIJ
English: You may be at a higher risk of serious blood clots or existing clots might become worse with Pergoveris treatment.
Slovenian: Morda je pri vas tveganje za resne krvne strdke večje ali se obstoječi strdki lahko poslabšajo ob jemanju zdravila Pergoveris.
English: A comparative clinical study between the freeze-dried and the liquid formulation showed bioequivalence between the two formulations.
Slovenian: Primerjalna klinična študija med liofiliziranim in tekočim pripravkom je pokazala bioekvivalenco med tema dvema pripravkoma.
English: Warning: Check that the Dose Feedback Window displays your complete prescribed dose before you move on to the next step.
Slovenian: Opozorilo: Preverite, ali okno za nastavitev odmerka prikazuje celotni predpisani odmerek, preden nadaljujete z naslednjim korakom.
English: • FSH stimulates the production of eggs
Slovenian: • FSH stimulira nastanek jajčec
English: If severe OHSS occurs, gonadotropin treatment should be stopped if still ongoing.
Slovenian: Če se pojavi hud OHSS, se mora ukiniti zdravljenje z gonadotropinom, v kolikor še traja.
English: Caution: Do not attach the needle too tightly; the needle could be difficult to remove after the injection.
Slovenian: Igle ne pritrdite preveč tesno; morda jo bo po injiciranju težko odstraniti.
English: • if you have large ovaries or sacs of fluid within your ovaries (ovarian cysts) of unknown origin
Slovenian: • če imate velike jajčnike ali vrečke tekočine znotraj jajčnikov (ciste jajčnika) neznanega izvora,
English: • Remove any air bubbles: If you see air bubbles in the syringe, hold the syringe with the needle pointing upwards and gently flick the syringe until all the air collects at the top.
Slovenian: • Odstranite morebitne zračne mehurčke: če vidite mehurčke zraka v brizgi, jo držite tako, da igla gleda navzgor in nežno krcajte (lahno udarjajte s prstom) brizgo, da se ves zrak zbere na vrhu.
English: Very rare (may affect up to 1 in 10,000 people): • Your asthma may get worse.
Slovenian: Zelo redki (pojavijo se lahko pri največ 1 od 10.000 bolnikov) • poslabšanje astme.
English: Therefore, if signs of OHSS occur such as serum oestradiol level > 5,500 pg/mL or > 20,200 pmol/L and/or ≥ 40 follicles in total, it is recommended that hCG be withheld and the patient be advised to refrain from coitus or to use barrier contraceptive methods for at least 4 days.
Slovenian: Zato je v primeru pojava znakov OHSS, kot so ravni estradiola v serumu > 5.500 pg/ml ali > 20.200 pmol/l in/ali skupno ≥ 40 foliklov, priporočljivo, da se opusti dajanje hCG in se bolnici svetuje, da se vzdrži spolnih odnosov ali uporablja mehanska kontracepcijska sredstva najmanj 4 dni.
English: Pergoveris treatment seldom causes severe OHSS.
Slovenian: Zdravljenje z zdravilom Pergoveris redko povzroči hud OHSS.
English: b. Verify a complete injection.
Slovenian: b. Preveriti popolnost injiciranja.
English: This becomes more likely if the medicine that is used for final follicular maturation (containing human chorionic gonadotrophin, hCG) is administered (see in section 3. under “How much to use” for details).
Slovenian: To je bolj verjetno, če se daje zdravilo, ki se uporablja za spodbuditev končnega folikularnega zorenja (ki vsebuje humani horionski gonadotropin - hCG) (za več podrobnosti glejte poglavje 3 „Koliko zdravila uporabiti“).
English: This side effect is very rare.
Slovenian: Ta neželeni učinek je zelo redek.
English: Your doctor will tell you how many IUs of follitropin alfa to inject each day.
Slovenian: Zdravnik vam bo povedal, koliko i.e. folitropina alfa si morate vsak dan injicirati.
English: The active substances in Pergoveris are copies of the natural hormones FSH and LH.
Slovenian: Učinkovini v zdravilu Pergoveris sta kopiji naravnih hormonov FSH in LH.
English: NOTE: Using your treatment diary to record your daily injection(s) allows you to verify that you received the full prescribed dose every day.
Slovenian: OPOMBA: Uporaba dnevnika zdravljenja za beleženje dnevnih injiciranj omogoča preverjanje, da ste vsak dan prejeli celotni predpisani odmerek.
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 25 June 2007
Slovenian: DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET Z ZDRAVILOM Datum prve odobritve: 25. junij 2007 Datum zadnjega podaljšanja: 8. maj 2017
English: In rare cases this can also happen independently of OHSS (see in section 2. under “Blood clotting problems (thromboembolic events)”).
Slovenian: V redkih primerih lahko pride do tega neodvisno od OHSS (glejte poglavje 2 pod „Težave s strjevanjem krvi (trombembolični dogodki)“).
English: Manufacturer Merck Serono S.p.A, Via delle Magnolie 15 (Zona industriale), I-70026 Modugno (Bari), Italy
Slovenian: Izdelovalec Merck Serono S.p.A, Via delle Magnolie 15 (Zona industriale), I-70026 Modugno (Bari), Italija
English: • After a minimum of 5 seconds, pull the needle out of the skin while keeping the dose setting knob pressed down (Fig. 11).
Slovenian: • Po vsaj 5 sekundah izvlecite injekcijsko iglo iz kože in še vedno držite pritisnjen gumb za nastavitev odmerka (sl. 11).
English: Treatment with Pergoveris should be initiated under the supervision of a physician experienced in the treatment of fertility problems.
Slovenian: Zdravljenje z zdravilom Pergoveris se mora začeti pod nadzorom zdravnika, ki je izkušen v zdravljenju težav s plodnostjo.
English: * The numbers on the Dose Feedback Window and reservoir holder represent the number of International Units (IU) of medication.
Slovenian: * Številke na oknu za prikaz odmerka in prostoru za tekočino predstavljajo število mednarodnih enot (i.e.) zdravila.
English: Pergoveris has no or negligible influence on the ability to drive and use machines.
Slovenian: Zdravilo Pergoveris nima vpliva ali ima zanemarljiv vpliv na sposobnost vožnje in upravljanja strojev.
English: • It is important that your hands and the items you use be as clean as possible
Slovenian: • Pomembno je, da so vaše roke in predmeti, ki jih uporabljate, kolikor je le mogoče čisti • Primerna površina je čista miza ali kuhinjska površina
English: • one sharps container for safe disposal of glass and needles
Slovenian: • posoda za ostre predmete za varno odlaganje stekla in igel
English: If you get lower abdominal pain, gain any weight rapidly, feel sick or are vomiting or if you have difficulty in breathing, talk to your doctor straight away.
Slovenian: Če se pojavijo bolečine v spodnjem delu trebuha, če hitro pridobite telesno maso, če vam je slabo ali bruhate ali imate težave z dihanjem, se takoj pogovorite z zdravnikom.
English: • Alcohol swabs (not included in the pack)
Slovenian: •alkoholne blazinice (niso vključene v pakiranju),
English: Patients with porphyria or a family history of porphyria should be closely monitored during treatment with Pergoveris.
Slovenian: Bolnice s porfirijo ali s porfirijo v družinski anamnezi, morajo biti med zdravljenjem z zdravilom Pergoveris skrbno nadzorovane.
English: In women, safe and effective use of Pergoveris calls for monitoring of ovarian response with ultrasound, alone or preferably in combination with measurement of serum oestradiol levels, on a regular basis.
Slovenian: Pri ženskah je za varno in učinkovito uporabo zdravila Pergoveris potrebno redno nadzorovanje odziva jajčnikov z ultrazvokom ali po možnosti z ultrazvokom v kombinaciji z merjenjem serumskih ravni estradiola.
English: Alternatively, intrauterine insemination (IUI) may be performed.
Slovenian: Alternativno, se lahko izvede intrauterina oploditev (IUI - Intrauterine Insemination).
English: • ovarian enlargement or ovarian cyst unrelated to polycystic ovarian disease and of unknown origin
Slovenian: • s povečanjem jajčnikov ali cisto jajčnika, ki ni povezana s policistično boleznijo ovarijev in je neznanega izvora;
English: It is for use in adult women (18 years old or above) who have low levels (severe deficiency) of “follicle stimulating hormone” (FSH) and “luteinising hormone” (LH).
Slovenian: Zdravilo je namenjeno odraslim ženskam (starim 18 let ali več) z nizkimi ravnmi (hudim pomanjkanjem) „folikel stimulirajočega horona“ (FSH) in „luteinizirajočega hormona“ (LH).
English: • The numbers displayed in the Dose Feedback Window help you to:
Slovenian: • Številke, prikazane v okencu za prikaz odmerka, vam bodo pomagale:
English: Pergoveris should not be administered as a mixture with other medicinal products, in the same injection, except follitropin alfa for which studies have shown that co-administration does not significantly alter the activity, stability, pharmacokinetic nor pharmacodynamic properties of the active substances.
Slovenian: Zdravila Pergoveris se ne sme dajati v obliki mešanice z drugimi zdravili v isti injekcijski brizgi, razen s folitropinom alfa, za katerega so študije pokazale, da njegovo sočasno dajanje ne spremeni pomembno učinka, stabilnosti, farmakokinetičnih ali farmakodinamičnih lastnosti učinkovin.
English: Before starting treatment, the couple's infertility should be assessed as appropriate and putative contraindications for pregnancy evaluated.
Slovenian: Pred začetkom zdravljenja se mora oceniti neplodnost para kot primerno ter ovrednotiti domnevne kontraindikacije za nosečnost.
English: Paediatric population There is no relevant use of this medicinal product in the paediatric population.
Slovenian: Pediatrična populacija To zdravilo ni namenjeno za uporabo pri pediatrični populaciji.
English: THEN
Slovenian: POTEM
English: Children and adolescents Pergoveris is not for use in children and adolescents below 18 years old.
Slovenian: Otroci in mladostniki Otroci in mladostniki do 18 leta starosti zdravila Pergoveris ne smejo uporabljati.
English: This side effect is uncommon (may affect up to 1 in 100 people).
Slovenian: Ta neželeni učinek je občasen (pojavi se lahko pri do 1 od 100 bolnic).
English: In case you are not ovulating and if the recommended dose and schedule of administration are adhered to, the occurrence of severe OHSS is less likely.
Slovenian: V primeru, da ne ovulirate in upoštevate priporočeni odmerek zdravljenja in shemo dajanja zdravila, je manj verjetno, da bi se pojavil OHSS.
English: The steady state volume of distribution is around 10-14 L. Lutropin alfa shows linear pharmacokinetics, as assessed by AUC which is directly proportional to the dose administered.
Slovenian: Volumen porazdelitve v stanju dinamičnega ravnovesja je približno 10-14 l. Lutropin alfa kaže linearne farmakokinetične lastnosti, kot so ocenili z AUC, ki je direktno sorazmerna danemu odmerku.
English: • Pick up your syringe and slowly inject the contents of the syringe into the vial of powder.
Slovenian: • Primite brizgo in počasi injicirajte vsebino brizge v vialo s praškom.
English: Pergoveris is contraindicated in patients with:
Slovenian: Zdravilo Pergoveris je kontraindicirano pri bolnicah:
English: • Record this remaining dose in the “Amount Set to Inject” section in the next row (column 6).
Slovenian: • Zabeležite preostali odmerek v poglavje "Količina, ki jo nastavite za injiciranje" v naslednji vrstici (stolpec 6).
English: Pregnancy and breast-feeding Do not use Pergoveris if you are pregnant or breast-feeding.
Slovenian: Nosečnost in dojenje Ne uporabljajte zdravila Pergoveris, če ste noseči ali če dojite.
English: Pergoveris contains potent gonadotrophic substances capable of causing mild to severe adverse reactions, and should only be used by physicians who are thoroughly familiar with infertility problems and their management.
Slovenian: Zdravilo Pergoveris vsebuje močni gonadotropni učinkovini, ki lahko povzročita blage do hude neželene učinke in ga zato smejo uporabljati samo zdravniki, ki dobro poznajo težave neplodnosti in njihovo obvladovanje.
English: Independent risk factors for developing OHSS include young age, lean body mass, polycystic ovarian syndrome, higher doses of exogenous gonadotrophins, high absolute or rapidly rising serum oestradiol level (> 900 pg/mL or > 3,300 pmol/L in anovulation), previous episodes of OHSS and large number of developing ovarian follicles (3 follicles of ≥ 14 mm in diameter in anovulation).
Slovenian: Neodvisni dejavniki tveganja za razvoj OHSS vključujejo mladost, mršavo telesno maso, sindrom policističnih jajčnikov, večje odmerke eksogenih gonadotropinov, visoke absolutne ali hitro naraščajoče serumske koncentracije estradiola ( > 900 pg/ml ali > 3.300 pmol/l v anovulaciji), predhodnje epizode OHSS in veliko število razvijajočih se ovarijskih foliklov (3 folikle s premerom ≥ 14 mm v anovulaciji).
English: Elimination Total clearance is 0.6 L/h and one-eighth of the follitropin alfa dose is excreted in the urine.
Slovenian: Izločanje Skupni očistek je 0,6 l/h in ena osmina odmerka folitropina alfa se izloči z urinom.
English: This could cause chest pain, breathlessness, stroke or heart attack.
Slovenian: Povzročijo lahko bolečino v prsnem košu, zasoplost, kap ali srčni napad.
English: • If you administer Pergoveris to yourself, please carefully read and follow section “Instructions for Use”.
Slovenian: • Če si zdravilo Pergoveris dajete sami, natančno preberite in upoštevajte poglavje „Navodila za uporabo“.
English: Following intravenous administration, lutropin alfa is rapidly distributed with an initial half-life of approximately one hour and eliminated from the body with a terminal half-life of about 10-12 hours.
Slovenian: Po intravenskem dajanju se lutropin alfa hitro porazdeli z začetnim razpolovnim časom približno 1 uro in se izloči iz telesa s končnim razpolovnim časom približno 10-12 ur.
English: Follitropin alfa
Slovenian: Folitropin alfa
English: If you do not see a tiny drop(s) of fluid at or near the tip the first time you use a new pen:
Slovenian: Če prvič ne opazite drobnih kapljic tekočine na konici ali blizu nje, uporabite nov napolnjeni injekcijski peresnik:
English: Self-administration should only be performed by patients who are well motivated, adequately trained and with access to expert advice.
Slovenian: Samo bolniki, ki so dobro motivirani, ustrezno poučeni in imajo dostop do strokovnega nasveta, si lahko dajejo zdravilo sami.
English: This is when you have developed a suitable follicle, as assessed using ultrasound scans and blood tests.
Slovenian: To je, ko se razvije ustrezen folikel, kot se oceni z ultrazvočnim slikanjem in krvnimi testi.
English: For instructions on the use of this medicinal product, see the package leaflet, section 'Instructions for use'.
Slovenian: Za navodila o uporabi tega zdravila glejte poglavje „Navodila za uporabo“ v priloženem navodilu.
English: If your body responds too strongly, your treatment will be stopped and you will not be given any hCG (see in section 2. under ”Ovarian hyperstimulation syndrome (OHSS)”).
Slovenian: Če se vaše telo čezmerno odzove, je treba vaše zdravljenje prekiniti in hCG ne boste dobili (glejte poglavje 2 „Sindrom hiperstimulacije jajčnikov (OHSS)“).
English: Warning: Do not recap the needle with the green inner shield, as it can lead to needle stick.
Slovenian: Opozorilo: Injekcijske igle ne zapirajte z zelenim notranjim ščitnikom, saj se lahko z iglo zbodete.
English: Adherence to recommended Pergoveris and FSH dosage and regimen of administration can minimise the risk of ovarian hyperstimulation.
Slovenian: Upoštevanje priporočenega odmerjanja zdravila Pergoveris in FSH in režima dajanja lahko zmanjšata tveganje hiperstimulacije jajčnikov.
English: Your ovaries may have over-reacted to the treatment and formed large sacs of fluid or cysts (see in section 2. under “Ovarian hyperstimulation syndrome (OHSS)”).
Slovenian: Vaši jajčniki so se morda prekomerno odzvali na zdravljenje in razvile so se velike vrečke s tekočino ali ciste jajčnikov (glejte poglavje 2 pod „Sindrom hiperstimulacije jajčnikov (OHSS)“).
English: Luteal phase support may be considered since lack of substances with luteotrophic activity (LH/hCG) after ovulation may lead to premature failure of the corpus luteum.
Slovenian: Pretehta naj se ali je potrebna podpora lutealne faze, ker pomanjkanje snovi z luteotropno aktivnostjo (LH/hCG) po ovulaciji lahko privede do prezgodnje odpovedi rumenega telesca.
English: Pergoveris is indicated for the stimulation of follicular development in adult women with severe LH and FSH deficiency.
Slovenian: Zdravilo Pergoveris je indicirano za spodbujanje razvoja foliklov pri odraslih ženskah s hudim pomanjkanjem LH in FSH.
English: Following repeated administration, follitropin alfa accumulates 3-fold achieving a steady-state within 3-4 days.
Slovenian: Po večkratnem dajanju, se folitropin alfa trikratno kopiči in doseže stanje dinamičnega ravnovesja v 3 do 4 dneh.
English: Do not use Pergoveris if you notice any visible signs of deterioration, if the liquid contains particles or is not clear.
Slovenian: Ne uporabljajte zdravila Pergoveris, če opazite kakršne koli vidne znake kvarjenja, če raztopina vsebuje delce ali ni bistra.
English: • gynaecological haemorrhages of unknown origin
Slovenian: • z ginekološkimi krvavitvami neznanega izvora;
English: A recommended regimen commences with one vial of Pergoveris daily.
Slovenian: Priporočeni režim se začne z eno vialo zdravila Pergoveris na dan.
English: and show the dose of follitropin alfa.
Slovenian: in prikazujejo odmerek folitropina alfa.
English: The usual starting dose is one vial of Pergoveris every day.
Slovenian: Običajni začetni odmerek je ena viala zdravila Pergoveris vsak dan.
English: • The OHSS may become severe with clearly enlarged ovaries, decreased urine production, weight gain, difficulty in breathing and/or possible fluid accumulation in your stomach or chest.
Slovenian: • OHSS lahko postane hud z izrazito povečanimi jajčniki, zmanjšanim nastajanjem urina, s pridobivanjem telesne mase, težavami dihanja in/ali morebitnim nabiranjem tekočine v trebuhu ali prsnem košu.
English: • local reactions at the injection site such as pain, itching, bruising, swelling or irritation.
Slovenian: • lokalne reakcije na mestu injiciranja, kot so bolečina, srbenje, modrica, oteklina ali razdraženost
English: Other medicines and Pergoveris Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.
Slovenian: Obvestite zdravnika ali farmacevta, če uporabljate, ste pred kratkim uporabljali ali pa boste morda začeli uporabljati katero koli drugo zdravilo.
English: • The Dose Feedback Window will indicate the missing amount you need to inject using a new pen.
Slovenian: • Okence za prikaz odmerka prikazuje manjkajočo količino, ki jo morate injicirati z novim injekcijskim peresnikom.
English: There have been isolated reports of non-serious allergic reactions to Pergoveris.
Slovenian: Obstajajo posamična poročila o neogrožajočih alergijskih reakcijah na zdravilo Pergoveris.
English: • Remove the syringe from the vial and set it down carefully.
Slovenian: • Brizgo odstranite z viale in jo previdno odložite.
English: • if you have cancer in your ovaries, womb or breasts
Slovenian: • če imate rak jajčnika, maternice ali dojke,
English: What Pergoveris is and what it is used for What you need to know before you use Pergoveris How to use Pergoveris
Slovenian: Kaj je zdravilo Pergoveris in za kaj ga uporabljamo Kaj morate vedeti, preden boste uporabili zdravilo Pergoveris Kako uporabljati zdravilo Pergoveris Možni neželeni učinki
English: c. Read the dose remaining to be injected with a second pen.
Slovenian: c. Prebrati preostanek odmerka, ki ga je treba injicirati z drugim peresnikom.
English: If you are not sure, talk to your doctor, pharmacist or nurse before using this medicine.
Slovenian: Če ste negotovi, se posvetujte z zdravnikom, farmacevtom ali medicinsko sestro, preden uporabite to zdravilo.